Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001274173-26-000069·4D Molecular Therapeutics, Inc.
Schedule 13G ownership disclosure
4D Molecular Therapeutics Inc
Common Stock · CUSIP: 35104E100
Event date: 2025-12-31
- Filing-level shares
- 4,635,875
- Percent of class
- 8.1%
- JANUS HENDERSON GROUP PLC
Shares: 4,635,875 · Class: 8.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-26-000069
- Form type
- SCHEDULE 13G
- Filer
- 4D Molecular Therapeutics, Inc.
- CIK
- CIK 1650648
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership